Arcus Biosciences, Inc. (RCUS) Net income 2016–2025
Arcus Biosciences, Inc. (RCUS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$353.0MFY2025 · since FY2016: -$18.0M → -$353.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$353.0M | -24.7% |
| FY2024 | -$283.0M | +7.8% |
| FY2023 | -$307.0M | -15.0% |
| FY2022 | -$267.0M | -603.8% |
| FY2021 | $53.0M | +143.1% |
| FY2020 | -$123.0M | -45.2% |
| FY2019 | -$84.7M | -70.8% |
| FY2018 | -$49.6M | +6.6% |
| FY2017 | -$53.1M | -195.4% |
| FY2016 | -$18.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice